Literature DB >> 705767

HLA and thyrotoxicosis (Graves' disease) in Chinese.

S H Chan, P P Yeo, K F Lui, G B Wee, K T Woo, P Lim, J S Cheah.   

Abstract

HLA locus A and B typing was performed on 86 Chinese thyrotoxicosis (Graves' Disease) patients and 238 normal Chinese subjects. The frequency of HLA-Bw46 (Sin 2) was found to be significantly higher among the patients than controls (x2 = 26.15, corrected P less than .003, relative risk = 3.74). The risk associated with Bw46 was reflected in the Bw46 heterozygotes. The relative risks of the joint occurrence of Bw46/B40 and Bw46/B13 were 8.74 and 5.88 respectively.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 705767     DOI： 10.1111/j.1399-0039.1978.tb01306.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN： 0001-2815


  10 in total

Review 1.  Role of genetic and non-genetic factors in the etiology of Graves' disease.

Authors:  M Marinò; F Latrofa; F Menconi; L Chiovato; P Vitti
Journal:  J Endocrinol Invest       Date:  2014-11-25       Impact factor: 4.256

2.  The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C.

Authors:  L D Barber; L Percival; N M Valiante; L Chen; C Lee; J E Gumperz; J H Phillips; L L Lanier; J C Bigge; R B Parekh; P Parham
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

3.  Strong association of HLA BW46 with juvenile onset myasthenia gravis in Hong Kong Chinese.

Authors:  B R Hawkins; W Y Chan-Lui; E K Choi; A Y Ho
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

4.  HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).

Authors:  C Papasteriades; M N Alevizaki-Harhalaki; J Economidou; D G Ikkos
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

Review 5.  Autoantigens in thyroid diseases.

Authors:  K Dawe; P Hutchings; B Champion; A Cooke; I Roitt
Journal:  Springer Semin Immunopathol       Date:  1993

6.  Human lymphocyte antigens (HLA) and Graves' disease in Turkey.

Authors:  Y Orhan; A Azezli; M Carin; F Aral; E Sencer; S Molvalilar
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

7.  Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles.

Authors:  Pei-Lung Chen; Cathy Shen-Jang Fann; Chen-Chung Chu; Chien-Ching Chang; Su-Wei Chang; Hsin-Yi Hsieh; Marie Lin; Wei-Shiung Yang; Tien-Chun Chang
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

8.  Association between HLA-B*46 allele and Graves disease in Asian populations: a meta-analysis.

Authors:  Yiping Li; Yufeng Yao; Man Yang; Li Shi; Xianli Li; Ying Yang; Ying Zhang; Chunjie Xiao
Journal:  Int J Med Sci       Date:  2013-01-03       Impact factor: 3.738

9.  Human leukocyte antigen (HLA) in Korean patients with autoimmune thyroid diseases.

Authors:  K B Huh; H C Lee; H M Kim; H R Lee; C S Hong; S Y Lee; H J Choi; K Park; C K Kim
Journal:  Korean J Intern Med       Date:  1986-07       Impact factor: 2.884

10.  The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands.

Authors:  Hugo G Hilton; Curtis P McMurtrey; Alex S Han; Zakia Djaoud; Lisbeth A Guethlein; Jeroen H Blokhuis; Jason L Pugh; Ana Goyos; Amir Horowitz; Rico Buchli; Ken W Jackson; Wilfred Bardet; David A Bushnell; Philip J Robinson; Juan L Mendoza; Michael E Birnbaum; Morten Nielsen; K Christopher Garcia; William H Hildebrand; Peter Parham
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.